Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: biosimilar

U.S. Top Court Debates Making Copycat Biologics Available Sooner

Andrew Chung  |  April 26, 2017

WASHINGTON (Reuters)—U.S. Supreme Court justices on Wednesday struggled over whether to speed up the time it takes to bring to the market copycat versions of biologic drugs, expensive medicines that can generate billions of dollars in sales for drug makers. The nine justices heard arguments in an appeal by Novartis AG of a lower court…

Filed under:Drug UpdatesProfessional Topics Tagged with:AmgenCopycat BiologicsfilgrastimNeupogenNovartis AGU.S. Supreme Court

ACR Leaders to Talk Policy with Congressional Leaders in D.C.

From the College  |  April 19, 2017

On May 11, ACR leaders will fly to Capitol Hill to meet with Congressional leaders on behalf of ACR and ARHP members. With so many pressing policy issues facing the medical community this year, we hope that you, too, will let your members of Congress know where you stand on the following issues: Support Medical…

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:Capitol HillCDC Arthritis ProgramDepartment of Defense (DoD)FY2018 Defense Appropriations BillFY2018 Labor-HHA Appropriations BillIndependent Payment Advisory Board (IPAB)National Institutes of Health (NIH)policy issues

The ACR Agenda in D.C.: Where We Stand in Mid-April

Angus B. Worthing, MD, FACP, FACR  |  April 19, 2017

Editor’s note: This blog by Dr. Worthing originally appeared on the ACR’s Advocacy Listserv. Here’s a perspective on the current climate in which your government affairs team works. As you read this list of observations, imagine you’re a lawmaker and try to find where the ACR’s agenda fits into the current landscape: Washington is highly…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:ACR Government Affairs CommitteeCapitol HillH1B visasimmigrationZombie Healthcare Bill

How to Be Heard: Tips for Efficient & Effective Advocacy

From the College  |  April 10, 2017

Did you know that there are more state legislators in this country than practicing rheumatologists? There are more than 7,300 state legislators alone, and each represents tens of thousands of constituents. As providers, you have a unique expertise that can be valuable to legislators in making decisions on biosimilars, research funding, insurance reform and a…

Filed under:From the CollegeLegislation & Advocacy Tagged with:AdvocacyIn-district meetingslegislatorsprovider constituentsstate legislators

S.C. Rheumatism Society Benefits from ACR Partnership

Gretchen Henkel  |  April 6, 2017

Editor’s note: This article will be the first in a series of articles highlighting the advocacy work done by state and local societies around the country. The South Carolina Rheumatism Society (SCRS) realizes multiple benefits from its association with the ACR, according to Jeffrey G. Lawson, MD, the society’s treasurer. One example of the support offered:…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Biologics Price Competition and Innovation Act of 2009biosimilar substitutionsH.B. 3438South Carolina Rheumatism Society

AHCA, ACR Health Policy & More

Angus B. Worthing  |  March 16, 2017

Editor’s note: This blog by Dr. Worthing originally appeared on the ACR’s Advocacy Listserv. What a month! House Republicans introduced their bill to repeal and replace Obamacare. The ACR has analyzed the bill and believes the American Health Care Act (AHCA) does not go far enough to help Americans with rheumatic diseases. Brief recap: The…

Filed under:From the CollegeLegislation & Advocacy Tagged with:ACR Government Affairs CommitteeAmerican Health Care Act (AHCA)health policyimmigration orderObamacareTrump administration

A New Administration Brings Updated ACR Policy Positions

Mary Beth Nierengarten  |  March 1, 2017

The ACR continues to broaden its advocacy efforts on issues critical to rheumatology, as described in updates to its 2017 health policy statements. Along with continuing to advocate for access to care and treatments, enhancements to rheumatology research and training the next generation of rheumatologists, the 2017 health policy statements address a number of new…

Filed under:Legislation & AdvocacyPractice SupportProfessional Topics Tagged with:Biosimilarshealth policyHealthcare ReformMACRA implementation

ACR Puts Forward Principles on Patient Access to Care

Mary Beth Nierengarten  |  March 1, 2017

As the 115th Congress and the Trump administration consider potential reforms to the healthcare system, including actions related to the Affordable Care Act (ACA), physicians around the country remain vitally concerned about the need to preserve and improve access to care for their patients. To that end, the ACR continues to lobby for policies that…

Filed under:Legislation & AdvocacyPractice SupportProfessional Topics Tagged with:Access to carechronic arthritishealthcare coveragehealthcare provisionsongoing careposition statementrheumatic diseases

ACR Urges CMMI to Test Transparently: Coalition offers principles to guide CMS’s care innovation efforts

Susan Bernstein  |  February 16, 2017

The Center for Medicare and Medicaid Innovation (CMMI), which develops concepts for healthcare payment and service delivery, must be transparent and engaged with all stakeholders as it tests new models, according to a coalition of 30 associations. On Feb. 10, the Healthcare Leaders for Accountable Innovation in Medicare Coalition, which includes the ACR, released six…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Center for Medicare and Medicaid Innovation (CMMI)CMMIguideline principlesHealthcare Leaders for Accountable Innovation in Medicare CoalitionMACRAMedicare Access and CHIP Reauthorization Act of 2015Quality Payment Program

The ACR Supports Practicing Rheumatologists

Sharad Lakhanpal, MBBS, MD  |  February 14, 2017

A new presidential administration took office in January 2017. Although no one truly knows what directions our government and economy will take, one projection is that healthcare regulatory and insurance coverage policies will change, possibly dramatically. In a time of uncertainty, rheumatologists and rheumatology health professionals can turn to the ACR/ARHP for support, guidance and…

Filed under:Patient PerspectivePractice Support Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)BillingCareerCodingEducationHealth Insurancephysician paymentrheumatologistrheumatologyRISE

  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 42
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences